By David Kappos ( May 25, 2022, 5:32 PM EDT) -- Sen. Elizabeth Warren, D-Mass., recently urged the Biden administration to reduce the price of a prostate cancer medicine, Xtandi, by seizing the developer's patent rights and licensing them to generic drug manufacturers.[1] The administration has this power, Warren contends, thanks to the march-in rights embedded in a 42-year-old law, the Bayh-Dole Act.[2]...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.